Log in to your Inderes Free account to see all free content on this page.
Devyser Diagnostics
79.80 SEK
+0.25 %
Less than 1K followers
DVYSR
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Devyser Diagnostics
P/B
Median 2021-2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share price (SEK) | 88.60 | 72.00 | 78.60 | 118.50 | 114.20 |
| Shares | 15.2 | 16.1 | 16.3 | 16.6 | 16.7 |
| Market cap | 1,345.7 | 1,160.8 | 1,280.0 | 1,961.7 | 1,901.8 |
| Enterprise value | 981.0 | - | - | - | - |
| EV/S | 10.5 | - | - | - | - |
| EV/EBITDA | neg. | - | - | - | - |
| EV/EBIT | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. |
| P/B | 3.23 | 2.69 | 3.32 | 5.62 | 5.37 |
| P/S | 14.4 | 9.2 | 7.6 | 9.0 | 7.6 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 91.2 % | 86.2 % | 75.5 % | 73.7 % | 75.4 % |
| Gearing ratio | 3.1 % | 4.9 % | 19.4 % | 16.9 % | 14.6 % |
Login required
This content is only available for logged in users